Insight Partners Backs 3Ventures to Catalyze Saudi Arabia’s AI-Led Startup Revolution

Riyadh, October 29, 2025 — Global venture powerhouse Insight Partners, renowned for scaling high-growth technology companies worldwide, is entering Saudi Arabia’s burgeoning innovation ecosystem through a strategic investment in 3Ventures. The partnership aims to accelerate the development of AI-led startups and reinforce the Kingdom’s long-term ambition of becoming a regional technology hub. 3Ventures, a Riyadh-based…

Read More

AM Batteries Secures $2.23M Grant to Launch Cutting-Edge Customer Success Center

AM Batteries (AMB), a leader in lithium-ion dry-electrode technology, has unveiled its state-of-the-art Customer Success Center, marking a significant milestone in advancing sustainable battery production. The center, funded by a $2.23 million grant from the Massachusetts Manufacturing Innovation Initiative (M2I2), is set to revolutionize the industry with its cutting-edge capabilities in dry-electrode manufacturing. AMB’s Customer…

Read More

Katara Secures $2.6 Million in Pre-seed and Seed Funding to Revolutionize DevX Automation

Katara, the innovative platform at the forefront of AI-driven workflow automation, has announced a remarkable $2.2 million in seed funding. The round, spearheaded by Diagram Ventures and Sparkle Ventures, with additional support from StreamingFast and key angel investors, brings the company’s total funding to $2.6 million when including its pre-seed round. The funds will be…

Read More

PortSwigger Secures €104.7 Million to Propel Growth in Web Security Realm

Cheshire-based PortSwigger, a distinguished provider of application security software, has announced a significant milestone with the securing of €104.7 million in funding from Brighton Park Capital, renowned for its investments in growth-stage technology and software enterprises. This substantial infusion of capital marks PortSwigger’s first external investment, earmarked to accelerate its expansion and innovation initiatives within…

Read More

PCORI Unveils $165 Million Investment in Groundbreaking Patient-Centered Health Research

In a transformative move for the health research sector, the Patient-Centered Outcomes Research Institute (PCORI) has announced a substantial funding commitment of over $165 million. This latest allocation supports a range of new comparative clinical effectiveness research (CER) projects designed to provide invaluable insights into patient care and treatment options. Among the awarded grants, notable…

Read More

Raycast Secures $30M Series B to Streamline Workflow and Enhance Productivity

In a significant leap toward enhancing workplace productivity, Raycast, a leading productivity software company, has successfully raised $30 million in a Series B funding round. This latest investment brings Raycast’s total funding to over $45 million, underscoring its mission to reduce context switching and optimize user focus. As the digital landscape becomes increasingly saturated with…

Read More

Gigpro Secures $16M Series A Financing to Revolutionize Hospitality Labor Market

Gigpro, a trailblazer in on-demand labor solutions for the hospitality sector, has successfully closed a $16 million Series A funding round. This substantial investment was spearheaded by Foundry, with notable participation from Stage 1 Ventures, Stage 2 Capital, and Detroit Venture Partners. The new capital will catalyze Gigpro’s mission to reshape the gig economy and…

Read More

Hgen Secures $5M Funding to Advance High-Efficiency Electrolyzer Technology

In a significant boost to the clean hydrogen sector, Hgen, a pioneering startup focused on decarbonizing heavy industry, has announced the successful closure of a $5 million seed financing round. The investment, led by Seven Seven Six, with notable participation from Founders Fund and Fontinalis Partners, will expedite the commercial deployment of Hgen’s innovative alkaline…

Read More

Vico Therapeutics Secures €65.8 Million in Series B Funding to Advance Groundbreaking Neurological Therapies

Vico Therapeutics, a pioneering clinical-stage genetic medicines company, has successfully closed its Series B funding round with a total investment of €65.8 million ($70.7 million). This financing round, led by Seroba and Kurma Partners, marks a significant milestone in Vico’s journey towards developing transformative therapies for severe neurological diseases. Vico Therapeutics specializes in antisense oligonucleotide…

Read More